1. Visceral leishmaniasis: An overview 2. Maintenance of Leishmania parasite 3. Host immunity and immunomodulation 4. VL and natural products 5. Antileishmanial drug screening 6. Vaccine and Vaccination 7. Different vaccination approaches for development of vaccine 8. Adjuvants 9. Vaccine delivery system 10. Routes of vaccination 11. Animal models for VL 12. Vaccination approaches for VL 13. Current status in Leishmania vaccine and problems to be solved 14. Amastigote based vaccine: Silver lining in Leishmaniasis
Dr. Awanish Kumar is currently an Associate Professor in the Department of Biotechnology at the National Institute of Technology, Raipur (CG), India. He is working in the area of infection biology, drug targeting, and drug discovery. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute-Lucknow, India and Jawaharlal Nehru University-Delhi, India. He did his post-doctoral study at McGill University, Montreal, Canada. Dr. Kumar has served various national and international organizations in different academic and research capacities. He has authored several monographs, books, and book chapters. He has served on many national committees, scientific society and advisory panels, is a member of many international professional research societies and as a reviewer and editorial board member of reputed and refereed journals.